Industry
Featured experience
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
AbbVie $15 billion senior notes offering
The investment-grade offering comprised seven tranches
Auna $360 million U.S. IPO
We advised Auna on its U.S. IPO and NYSE listing
Trial victory in patent infringement case for Magnolia Medical Technologies
We served as lead trial counsel for Magnolia Medical in an action against its sole competitor
Jounce Therapeutics, Inc. Initial Public Offering
Davis Polk advised the lead book-running manager and representative of the underwriters in connection with its $101.9…
Davis Polk Advises Affimed on Its $18 Million Offering of Shares
Davis Polk advised Affimed N.V. on its $18 million public offering of 10,000,000 of its common shares. The underwriters have…
Davis Polk Successfully Represents Aetna in Patent Infringement Suit
Davis Polk represents Aetna Inc. and its subsidiaries ActiveHealth Management, Inc. and Medicity, Inc. in a patent…
Loxo Oncology, Inc. Common Stock Offering
Davis Polk advised the joint book-running managers in connection with a $138 million SEC-registered offering of 4,450,500…
Magellan Pharmacy Services, Inc. $200 Million Term Loan
Davis Polk advised the administrative agent in connection with a $200 million delayed draw term loan facility for…
Sucampo Pharmaceuticals, Inc. $300 Million Convertible Senior Notes Offering
Davis Polk advised the sole book-running manager and initial purchaser in connection with a Rule 144A offering by Sucampo…
Davis Polk Advises Roche on Its $250 Million Cash Tender Offer
Davis Polk advised Roche Holdings, Inc. in connection with a cash tender offer for up to $250 million aggregate principal…
Achaogen, Inc. Follow-On Offering
Davis Polk advised the joint book-running managers in connection with the $100.9 million public offering of common stock of…
Yestar International Holdings Company Limited Placement of Shares
Davis Polk advised the sole placing agent in connection with the placing of 38,500,000 shares held by China Asset Management…
Xencor, Inc. Follow-On Offering
Davis Polk advised the sole book-running manager in connection with the $126.5 million public offering of common stock of…